At Health Enterprise East we believe in improving healthcare through technology and innovation
The University of South Wales (USW) sought to commercialise a novel point of care device, developed by USW researchers, for rapidly testing COVID-19. The Brief The University was working with Public Health Wales, the University Health Board and local industry to collaboratively develop the device to meet regulatory, clinical and commercial requirements. The University required […]
Professor Vincent Gnanapragasam and colleagues developed the Cambridge Prostate Biopsy Device (CamPROBE®), an innovative device to safely access the prostate using fewer incisions through the perineum instead of via the transrectal route. As such, the device reduces the risk of infection.
Each year, around 2,800 people in the UK experience a hole in their upper gastrointestinal (GI) tract. The presence of a hole allows leakage of gastrointestinal contents into the body which quickly leads to infection – a serious medical emergency that can be fatal if not treated. ENDOVAC™ is a pioneering endoscopic surgical device to solve this problem.
Radiofrequency Ablation (RFA) is an established technique for the treatment of soft tissue with applications in oncology, women’s health and cardiology. RFA uses Alternating Current to generate radiofrequency (RF) energy, which when delivered to target tissues via a probe, results in localised heating and tissue destruction.
Arterial lines are frequently used in intensive care units and operating theatres to facilitate beat-to-beat monitoring of blood pressure and to allow blood sampling. The Needle-Free Arterial Non-injectable Connector (NIC) is a novel device which increases the safety of patients undergoing blood sampling.
A new approach to treating prominent ears, which affects 5-10% of the UK population, was developed by Dr Norbert Kang using an implant manufactured from a high technology memory metal which can be inserted subcutaneously under the skin of the ear. This quick and effective procedure performed under local anaesthetic has fewer side effects than conventional otoplasty surgery and is less invasive.
It is conservatively estimated that 4M temporary tracheostomies are performed throughout Europe and the US each year. The procedure involves making an incision on the anterior aspect of the neck, and opening a direct airway through an incision in the trachea. Tracheseal is a dedicated tracheostomy wound dressing to be used after the removal of the tracheostomy tube.
Regional anaesthesia is directed at a specific region of the body to allow a surgical operation or provide post-operative pain relief. SAFIRA makes regional anaesthesia a one person procedure, putting control in the hands of the anaesthesiologist.
Health Tech Enterprise is a trademark of Health Enterprise East Ltd.
© 2025 Health Enterprise East Ltd, St John's Innovation Centre, Cowley Road, Cambridge CB4 0WS
Email: enquiries@healthtechenterprise.co.uk Tel: +44 (0) 1223 422 422